Matthew L. Sherman - Jan 17, 2023 Form 4 Insider Report for Deciphera Pharmaceuticals, Inc. (DCPH)

Role
EVP & Chief Medical Officer
Signature
/s/ Jeffrey M. Held, Attorney-in-Fact
Stock symbol
DCPH
Transactions as of
Jan 17, 2023
Transactions value $
-$51,043
Form type
4
Date filed
1/19/2023, 03:05 PM
Previous filing
Oct 5, 2022
Next filing
Feb 17, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction DCPH Common Stock Sale -$51K -2.4K -3.2% $21.24 72.6K Jan 17, 2023 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This sale was to cover tax liabilities in the vesting of restricted stock.
F2 Includes 734 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on November 14, 2022.